Loading…
Punctuated evolution of canonical genomic aberrations in uveal melanoma
Cancer is thought to arise through the accumulation of genomic aberrations evolving under Darwinian selection. However, it remains unclear when the aberrations associated with metastasis emerge during tumor evolution. Uveal melanoma (UM) is the most common primary eye cancer and frequently leads to...
Saved in:
Published in: | Nature communications 2018-01, Vol.9 (1), p.116-116, Article 116 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cancer is thought to arise through the accumulation of genomic aberrations evolving under Darwinian selection. However, it remains unclear when the aberrations associated with metastasis emerge during tumor evolution. Uveal melanoma (UM) is the most common primary eye cancer and frequently leads to metastatic death, which is strongly linked to
BAP1
mutations. Accordingly, UM is ideally suited for studying the clonal evolution of metastatic competence. Here we analyze sequencing data from 151 primary UM samples using a customized bioinformatic pipeline, to improve detection of
BAP1
mutations and infer the clonal relationships among genomic aberrations. Strikingly, we find
BAP1
mutations and other canonical genomic aberrations usually arise in an early punctuated burst, followed by neutral evolution extending to the time of clinical detection. This implies that the metastatic proclivity of UM is “set in stone” early in tumor evolution and may explain why advances in primary treatment have not improved survival.
Uveal melanoma (UM), the most common primary eye cancer, is strongly linked to mutations in the tumor suppressor
BAP1
. Here, the authors analyze 151 primary UM samples to find that
BAP1
and other canonical genomic aberrations arise in an early punctuated burst followed by neutral tumor evolution. |
---|---|
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/s41467-017-02428-w |